Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer, Endometrial Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06502743
What this trial is testing

First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial CancerRecurrent Endometrial CarcinomaEndometrial Carcinoma+2 more
Yonsei University 92
Early research (Phase 1)Ended earlyNCT04586335
What this trial is testing

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Who this might be right for
Ovarian CancerBreast CancerSolid Tumor+2 more
Haihe Biopharma Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03339843
What this trial is testing

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

Who this might be right for
Esophageal AdenocarcinomaEsophagus SCCCholangiocarcinoma+2 more
Jules Bordet Institute 85
Testing effectiveness (Phase 2)Study completedNCT02025985
What this trial is testing

Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies

Who this might be right for
Ovarian CarcinomaEndometrial CarcinomaCervical Carcinoma
Karyopharm Therapeutics Inc 116
Testing effectiveness (Phase 2)UnknownNCT03951415
What this trial is testing

Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer

Who this might be right for
Endometrial NeoplasmsUterine NeoplasmsEndometrium Cancer
Leiden University Medical Center 55
Testing effectiveness (Phase 2)Ended earlyNCT00503581
What this trial is testing

Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia

Who this might be right for
High Grade Squamous Intraepithelial NeoplasiaStage 0 Uterine Corpus Cancer
Gynecologic Oncology Group 9
Not applicableStudy completedNCT00026689
What this trial is testing

Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

Who this might be right for
ProstateBrainBreast+2 more
National Cancer Institute (NCI) 903
Testing effectiveness (Phase 2)Study completedNCT03314935
What this trial is testing

INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Who this might be right for
Biliary Tract Cancer (BTC)Colorectal Cancer (CRC)Endometrial Cancer+3 more
Incyte Corporation 149
Not applicableLooking for participantsNCT07327489
What this trial is testing

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Who this might be right for
CancerImmunotherapyAdvanced Solid Tumors Cancer+12 more
Elephas 2,000
Testing effectiveness (Phase 2)Study completedNCT02725268
What this trial is testing

Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Millennium Pharmaceuticals, Inc. 241
Not applicableStudy completedNCT06102252
What this trial is testing

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

Who this might be right for
Endometrial Carcinoma
Sohag University 60
Testing effectiveness (Phase 2)Study completedNCT03189446
What this trial is testing

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer

Who this might be right for
Endometrial CancerPapillary SerousClear Cell Endometrial Cancer
University of Oklahoma 39
Not applicableLooking for participantsNCT05349227
What this trial is testing

Comprehensive Outcomes for After Cancer Health

Who this might be right for
Ovarian CancerBreast CancerLung Cancer+8 more
Pack Health 625
Testing effectiveness (Phase 2)Looking for participantsNCT05902988
What this trial is testing

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more
Volastra Therapeutics, Inc. 200
Not applicableUnknownNCT05287048
What this trial is testing

Evaluation of MCM5 in Postmenopausal Bleeding Patients

Who this might be right for
Endometrial Cancer
Arquer Diagnostics Ltd 2,000
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Large-scale testing (Phase 3)UnknownNCT00726635
What this trial is testing

The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies

Who this might be right for
Cancer of CervixOvarian CancerCancer of Endometrium
Rabin Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00087685
What this trial is testing

RAD001 in Recurrent Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 35
Very early researchUnknownNCT05812677
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial CancerAdvanced Cancer
Shanghai Yunying Medical Technology 20
Early research (Phase 1)Looking for participantsNCT05410717
What this trial is testing

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
Stage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more
Second Affiliated Hospital of Guangzhou Medical University 200
Next Page